Biochemistry-informed design selects potent siRNAs against SARS-CoV-2
RNA interference (RNAi) offers an efficient way to repress genes of interest, and it is widely used in research settings. Clinical applications emerged more recently, with 5 approved siRNAs (the RNA guides of the RNAi effector complex) against human diseases. The development of siRNAs against the SA...
Main Authors: | Élisabeth Houbron, Sophie Mockly, Sophia Rafasse, Nathalie Gros, Delphine Muriaux, Hervé Seitz |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | RNA Biology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/15476286.2023.2217400 |
Similar Items
-
Nanoparticles and siRNA: A new era in therapeutics?
by: María Dolores Pérez-Carrión, et al.
Published: (2024-03-01) -
Implications of siRNA Therapy in Bone Health: Silencing Communicates
by: Puneetpal Singh, et al.
Published: (2024-01-01) -
Therapeutic siRNAs: small molecules with bigger function
by: Ruby Dhar, et al.
Published: (2024-01-01) -
Strategies for ocular siRNA delivery: Potential and limitations of non-viral nanocarriers
by: Thakur Ajit, et al.
Published: (2012-06-01) -
Advances in siRNA therapeutics and synergistic effect on siRNA activity using emerging dual ribose modifications
by: Sumit Gangopadhyay, et al.
Published: (2022-12-01)